Gassmann M, Mairburl H, Livshits L, Hackbusch M, Malczyk M, Kraut S, et al
At baseline, most patients (97%) were treated with one or more glucose-lowering medications, including metformin (76%), insulin (51%), SGLT-2i (27%), sulfonylurea (29%), and DPP-4i (23%) with CV disease and risk factors managed with lipid-lowering medications (89%), platelet-aggregation inhibitors including aspirin (77%), angiotensin converting enzyme inhibitors or angiotensin II receptor blockers (79%), and beta blockers (64%)
These calories are suitable for everyday intake, but taking multiple servings of bananas with milk daily can significantly contribute to calorie intake
Semaglutide is a GLP-1 agonist that stimulates insulin production and slows gastric emptying, leading to improved blood sugar control and weight loss